{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T13:04:31Z","timestamp":1759496671186},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.neuropharm.2006.08.017","type":"journal-article","created":{"date-parts":[[2006,10,6]],"date-time":"2006-10-06T12:59:46Z","timestamp":1160139586000},"page":"487-496","source":"Crossref","is-referenced-by-count":17,"title":["Evidence for adenosine- and serotonin-mediated antihyperalgesic effects of cizolirtine in rats suffering from diabetic neuropathy"],"prefix":"10.1016","volume":"52","author":[{"given":"Bertrand","family":"Aubel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Kayser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Farr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Hamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Bourgoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2006.08.017_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1358\/mf.2000.22.4.584453","article-title":"Pharmacology of cizolirtine: a new analgesic agent","volume":"22","author":"Alvarez","year":"2000","journal-title":"Meth. Find Exp. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-510X(01)00584-6","article-title":"Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials","volume":"189","author":"Apfel","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib3","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/00001756-199608120-00023","article-title":"Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord","volume":"7","author":"Arvieu","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pain.2004.03.001","article-title":"Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies","volume":"110","author":"Aubel","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0028-3908(00)00186-6","article-title":"The novel analgesic, cizolirtine, inhibits the spinal release of substance P and CGRP in rats","volume":"40","author":"Ballet","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib6","first-page":"713","article-title":"Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain","volume":"81","author":"Belfrage","year":"1995","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1213\/00000539-199907000-00023","article-title":"The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain","volume":"89","author":"Belfrage","year":"1999","journal-title":"Anesth. Analg"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3959(93)90059-X","article-title":"Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain","volume":"53","author":"Courteix","year":"1993","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib9","first-page":"88","article-title":"Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine","volume":"239","author":"DeLander","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib10","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/sj.bjp.0703170","article-title":"The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors","volume":"129","author":"El Yacoubi","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(88)90356-3","article-title":"Heterogeneous effects of serotonin in the dorsal horn of rat: the involvement of 5-HT1 receptor subtypes","volume":"456","author":"El-Yassir","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-2999(00)00336-8","article-title":"Caffeine blockade of the thermal antihyperalgesic effect of acute amitriptyline in a rat model of neuropathic pain","volume":"399","author":"Esser","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1358\/dof.2002.027.08.692100","article-title":"Cizolirtine citrate","volume":"27","author":"Farr\u00e9","year":"2002","journal-title":"Drugs Future"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3959(02)00321-4","article-title":"Characterization of the analgesic actions of adenosine: comparison of adenosine and remifentanil infusions in patients undergoing major surgical procedures","volume":"101","author":"Fukunaga","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1254\/jjp.82.130","article-title":"Antinociception induced by amitriptyline and imipramine is mediated by alpha2A-adrenoceptors","volume":"82","author":"Ghelardini","year":"2000","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib16","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/00000542-199910000-00028","article-title":"Intrathecal adenosine interacts with a spinal noradrenergic system to produce antinociception in nerve-injured rats","volume":"91","author":"Gomes","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib17","series-title":"Novel Aspects of Pain Management: Opioids and Beyond","first-page":"203","article-title":"Serotonin and its receptors in pain control","author":"Hamon","year":"1999"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0006-8993(99)01780-1","article-title":"The antinociceptive effect of the mu-opioid fentanyl is reduced in the presence of the alpha(2)-adrenergic antagonist idazoxan in inflammation","volume":"840","author":"Herrero","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0091-3057(02)00840-7","article-title":"Comparison of the ability of adenosine kinase inhibitors and adenosine receptor agonists to attenuate thermal hyperalgesia and reduce motor performance in rats","volume":"73","author":"Jarvis","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib20","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/sj.bjp.0704979","article-title":"The antimigraine 5-HT1B\/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain","volume":"137","author":"Kayser","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3959(02)00497-9","article-title":"Effects of the novel analgesic, cizolirtine, in a rat model of neuropathic pain","volume":"104","author":"Kayser","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-8993(92)91490-6","article-title":"Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia","volume":"597","author":"Kiefel","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568007043482570","article-title":"5-HT1 receptors","volume":"3","author":"Lanfumey","year":"2004","journal-title":"Curr. Drug Targets \u2013 CNS Neurol. Disord."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01276459","article-title":"Effects of dorsal rhizotomy and selective lesion of serotonergic and noradrenergic systems on 5-HT1A, 5-HT1B, and 5-HT3 receptors in the rat spinal cord","volume":"100","author":"Laporte","year":"1995","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0304-3959(98)00193-6","article-title":"Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain","volume":"80","author":"Lavand'homme","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00000542-199308000-00012","article-title":"Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction","volume":"79","author":"Malmberg","year":"1993","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1185\/0300799009117014","article-title":"Dose response and safety of cizolirtine citrate (E-4018) in patients with pain following extraction of third molars","volume":"16","author":"Matthew","year":"2000","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-2999(01)01619-3","article-title":"Adenosine receptor-mediated control of in vitro release of pain-related neuropeptides from the rat spinal cord","volume":"441","author":"Mauborgne","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain","volume":"66","author":"Millan","year":"2002","journal-title":"Progr. Neurobiol."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0304-3959(97)00186-3","article-title":"Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat","volume":"74","author":"Poon","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0304-3940(84)90397-5","article-title":"Antinociceptive effects in mice after intrathecal injection of 5\u2032-N-ethylcarboxamide adenosine","volume":"51","author":"Post","year":"1984","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib32","first-page":"409","article-title":"A method for measurement of analgesic activity on inflamed tissue","volume":"61","author":"Randall","year":"1957","journal-title":"Arch. Int. Pharmacodyn."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0304-3940(92)90752-S","article-title":"Adenosine inhibits action potential-dependent release of calcitonin gene-related peptide- and substance P-like immunoreactivities from primary afferents in rat spinal cord","volume":"144","author":"Santicioli","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0301-0082(03)00050-9","article-title":"Adenosine in the spinal cord and periphery: release and regulation of pain","volume":"69","author":"Sawynok","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib35","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1476-5381.1992.tb09047.x","article-title":"Anpirtoline, a novel, highly potent 5-HT1B receptor agonist with antinociceptive\/antidepressant-like actions in rodents","volume":"105","author":"Schlicker","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib36","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0306-4522(03)00480-9","article-title":"Distribution of antinociceptive adenosine A1 receptors in the spinal cord dorsal horn, and relationship to primary afferents and neuronal subpopulations","volume":"121","author":"Schulte","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.08.017_bib37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1185\/030079901753403153","article-title":"Cizolirtine citrate (E-4018) in the treatment of chronic neuropathic pain","volume":"17","author":"Shembalkar","year":"2001","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib38","first-page":"1013","article-title":"Intracerebroventricular morphine releases adenosine and adenosine 3\u2032,5\u2032-cyclic monophosphate from the spinal cord via a serotonergic mechanism","volume":"259","author":"Sweeney","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(02)00491-3","article-title":"Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats","volume":"328","author":"Ulugol","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib40","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1213\/00000539-199812000-00028","article-title":"Reduced anti-allodynic effect of the adenosine A1-receptor agonist R-phenylisopropyladenosine on repeated intrathecal administration and lack of cross-tolerance with morphine in a rat model of central pain","volume":"87","author":"von Heijne","year":"1998","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib41","first-page":"1182","article-title":"Serotonin receptor subtypes in spinal antinociception in the rat","volume":"269","author":"Xu","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000539-200207000-00029","article-title":"An investigation of monoamine receptors involved in antinociceptive effects of antidepressants","volume":"95","author":"Yokogawa","year":"2002","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2006.08.017_bib43","first-page":"349","article-title":"Serotonin receptor subtypes and the modulation of pain transmission","volume":"Vol. 77","author":"Zemlan","year":"1988"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806002899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806002899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T07:05:36Z","timestamp":1683615936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390806002899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0028390806002899"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2006.08.017","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}